Chris@CNW, Author at CannabisNewsWire

ThursdayAug 08, 2024 9:45 am

NECANN’s Michigan Cannabis Convention Offers Unique Business Ideas for Cannabis Sector

Businesses, entrepreneurs, investors, educators, patients, advocates, and consumers are invited to attend the NECANN Michigan Cannabis Convention on September 20-21, 2024, in Grand Rapids. NECANN events are organized to meet the needs and provide collaborative opportunities for the local cannabis community. One of the biggest cannabis conventions in the country, NECANN events witness some of the most eminent dignitaries of the cannabis spectrum gracing the event floor. Instead of hosting generic cannabis conventions, NECANN took a customized approach. As every region has its challenges, NECANN understands the specific requirements relevant to the area. They collaborate with local traders, growers, investors,…

ThursdayAug 08, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity Treatments

Lexaria, a global innovator in drug delivery platforms, is exploring alternatives to traditional diabetes and obesity management through its patented DehydraTECH(TM) technology to potentially enhance oral ingestion vs. injection treatment of GLP-1 drugs The company has made significant strides pairing their bioavailability enhancing DehydraTECH with glucagon-like peptide-1 (“GLP-1”) drugs used for treatment of diabetes and obesity Projections are that by 2030 over 54.9 of Americans could have diabetes, and that by 2045 one in eight adults globally will be living with the condition According to the International Diabetes Federation Diabetes Atlas of 2021, 10.5% of adults aged between 20 and…

WednesdayAug 07, 2024 4:20 pm

420 with CNW — Legalizing Medical Cannabis in North Carolina Still Faces Huge Hurdles

For the third year in a row, the senate of North Carolina approved the Compassionate Care Act. The measure aims to allow the sale of marijuana and marijuana-infused products to patients who qualify under a set of strict conditions, utilizing a regulated medical marijuana system. Despite this progress, the legislation is presently stuck in the house. Adding to the complexity, a recent decision by the Supreme Court has influenced the discussion around reclassifying marijuana as a Schedule 3 drug. Changing its classification from Schedule 1 to Schedule 3 would formally recognize its medical use, representing a small yet significant step…

WednesdayAug 07, 2024 10:00 am

Missouri Bans Sale of Delta-8 Intoxicants

The state of Missouri has placed a ban on the sale of candy, beverages and other edible products manufactured from intoxicating substances derived from hemp. Missouri is not the only state to regulate and/or impose a ban on delta-8 THC, with the move coming after the state’s governor Mike Parson issued an executive order on the same last week. The ban is set to go into effect from Sept. 1, 2024. In his order, the governor stated that lack of research on delta-8 THC and similar unregulated CBD compounds as well as health concerns were the basis for the ban.…

WednesdayAug 07, 2024 9:45 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”

The report explores the growth, competition, and consumer trends, for lesser known cannabinoids The report highlights a 5.4% revenue increase in the edible market for 2023, with total sales reaching $2.097 billion As consumer preferences shift towards edibles for their therapeutic effects and consistent experiences, the industry product landscape is set to evolve With the increasing acceptance of cannabis use in society, the popularity of edibles—products containing cannabinoids that can be consumed as food or drink—has surged. While many consumers are familiar with edibles containing THC (tetrahydrocannabinol), known for its euphoric effects, or CBD (cannabidiol), recognized for its therapeutic benefits,…

TuesdayAug 06, 2024 4:20 pm

420 with CNW — CU Anschutz Researchers Studying Users’ Capacity to Drive Under Influence of Marijuana

Researchers at the CU Anschutz School of Public Health have embarked on a paid study focusing on marijuana users to examine impairment levels. Over the past two years, the research has involved more than 200 participants aged between 25 and 55 years. Depending on the amount of marijuana consumed, each study session can last anywhere from three to five hours. Dr. Ashley Brooks-Russell, a lead researcher at the school, explained, “This study allows us to observe the changes people experience after consuming cannabis, including alterations in driving behavior, reaction times, memory, blood composition and eye characteristics. Police officers, in particular,…

MondayAug 05, 2024 4:20 pm

420 with CNW — Study Says Medical Marijuana Legalization Increases Parenting Time, Boosts Child Development

A recent study indicates that the availability of medical cannabis might lead to increased parenting time by improving patients’ overall health. Published in the “Journal of Applied Economics,” the research notes that medical cannabis legalization enhances sleep and reduces inactivity, aligning with its health benefits. According to the study, the legalization of medical cannabis can have a positive effect on a child’s development by allowing parents to spend more time with their kids, particularly if they are younger than six years old, a critical age for parental involvement. These advantages, however, are dependent on parents not abusing cannabis. Legalizing medical…

MondayAug 05, 2024 10:00 am

Latest NY Crackdown on Illicit Marijuana Outlets Starting to Stem the Vice

When the state of New York legalized adult-use marijuana, thousands of retail outlets started selling the substance without first obtaining licenses. These illegal establishments defied the authorities and remained open for more than a year due to lax enforcement. However, their luck turned when the state enacted new regulations in April. The office of the sheriff in New York City reveals that since the laws were strengthened in April, approximately 700 unlicensed cannabis shops have been closed. This success is largely attributed to the increased enforcement powers that local authorities were given in the new laws, and the opening of…

FridayAug 02, 2024 4:20 pm

420 with CNW — Nearly 43,000 Comments Sent to the DEA; Highlights Shared Here

The public comment period for the U.S. Drug Enforcement Administration’s (DEA) proposed marijuana rescheduling rules recently ended, and now the agency will analyze the responses, marking the first time they are considering public opinions on cannabis. Approximately 43,000 comments were submitted by individuals, researchers and organizations, making it the highest number of responses the DEA has ever received for a proposed regulation change. The drug markets and legal regulation director at the Drug Policy Alliance, Cat Packer, highlighted that the huge response demonstrates the public's great interest in cannabis legalization in the United States. People used this opportunity to share…

FridayAug 02, 2024 10:00 am

NTSB Writes to DEA Expressing Concerns about Marijuana Rescheduling

Earlier this month, the National Transportation Safety Board (NTSB) wrote to the U.S. Drug Enforcement Administration (FDA) highlighting its concerns regarding a rule that would reschedule marijuana under the Controlled Substances Act. The board explained that moving marijuana to Schedule 3 would prevent continued testing for cannabis use by transportation employees as labs certified by the U.S. Department of Health and Human Services (HHS) aren’t permitted to test for substances under this category. It implored the DEA to make sure that rescheduling cannabis didn’t compromise employee testing as this would have implications on the certification of school bus drivers. The…